If I remember correctly, when we first started the mTNBC trial, one of the stats most important was length of survival time. I haven't seen much made of that since. Of the 20+ patients we know five are still with us. What I would like to know, and in my ignorance considers important, is what is the mean survival time of all patients and how does that compare to SOC? Did they live longer than SOC? Does LL treatment hint at greater overall survival?